UK becomes first to authorize Merck and Ridgeback Biotherapeutics’ antiviral molnupiravir to treat mild-to-moderate Covid-19 – CNN

Category:
Icon 0
Icon 11월 4, 2021

UK becomes first to authorize Merck and Ridgeback Biotherapeutics’ antiviral molnupiravir to treat mild-to-moderate Covid-19  CNNUK authorizes Merck antiviral pill, 1st shown to treat COVID  Yahoo NewsEngland’s No. 2 doctor warns of ‘hard months to come in the winter’ from COVID  NPRFirst pill to treat Covid gets approval in UK  BBC NewsBritain approves Merck’s COVID-19 pill in world first  Yahoo News

답글 남기기

이메일 주소는 공개되지 않습니다. 필수 항목은 *(으)로 표시합니다